Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

BETAPACE

SOTALOL HYDROCHLORIDE

Standard Dose
80MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview BETAPACE is listed in Drugs@FDA under application 019865 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SOTALOL HYDROCHLORIDE Form and strength TABLET;ORAL - 80MG Sponsor LEGACY PHARMA Submission history Latest submission status date: 2023-06-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview BETAPACE is listed in Drugs@FDA under application 019865 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SOTALOL HYDROCHLORIDE Form and strength TABLET;ORAL - 80MG Sponsor LEGACY PHARMA Submission history Latest submission status date: 2023-06-15 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.